A randomized clinical trial assessing theranostic-guided corneal cross-linking for treating keratoconus: the ARGO protocol

The Assessment of theranostic guided riboflavin/UV-A corneal cross-linking for treatment of keratoconus (ARGO; registration number NCT05457647) clinical trial tests the hypothesis that theranostic-guided riboflavin/UV-A corneal cross-linking (CXL) can provide predictable clinical efficacy for haltin...

Descripción completa

Detalles Bibliográficos
Autores principales: Roszkowska, Anna Maria, Lombardo, Giuseppe, Mencucci, Rita, Scorcia, Vincenzo, Giannaccare, Giuseppe, Vestri, Annarita, Alunni Fegatelli, Danilo, Bernava, Giuseppe Massimo, Serrao, Sebastiano, Lombardo, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313539/
https://www.ncbi.nlm.nih.gov/pubmed/36587174
http://dx.doi.org/10.1007/s10792-022-02628-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313539/
https://www.ncbi.nlm.nih.gov/pubmed/36587174
http://dx.doi.org/10.1007/s10792-022-02628-4

Ejemplares similares